Qilian International Holding Group ltd
QLI
Get informed when a big investor buys or sells
+ FollowMarket Cap$56.58M
Close$
$0.43
92.1% downside
Current Fair Value
92.1% downsideOvervalued by 92.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $56.58 Million |
|---|---|
| Enterprise Value | $51.84 Million |
| Dividend Yield | $0.05 (-) |
| Earnings per Share | $-0.22 |
| Beta | 1.41 |
| Outstanding Shares | 35,750,000 |
Return
| Return on Equity | -7.13% |
|---|---|
| Return on Assets | -6.43% |
| Return on Invested Capital | -4.84% |
Valuation & Multiples
| P/E Ratio | -24.59 |
|---|---|
| PEG | 0.42 |
| Price to Sales | 5.41 |
| Price to Book Ratio | 0.54 |
| Enterprise Value to Revenue | 0.76 |
| Enterprise Value to EBIT | -2.73 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Qilian International Holding Group ltd
292 employeesQilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycl...